MPLT
MapLight Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.30 / 10
Outperform
Sentiment is bullish (7.3/10) and fund‑flow score 7.67 indicates strong inflows, especially from small and medium investors. Block trades are negative. Analysts unanimously issue a Strong Buy, reinforcing positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-19
InstitutionCanaccord Genuity
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for MPLT?
- MPLT holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.30/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
